An experimental drug may help prevent the chemotherapy drug doxorubicin from harming the heart and does so without interfering with doxorubicin’s ability to kill cancer cells, according to a study in mice.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3e1Tioe
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3e1Tioe